Evidence map›Paper›PMID 29330741›Full record

ArticleClinical rheumatology2018

Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.

Yunjia Tang, Wenhua Yan, Ling Sun, Qiuqin Xu, Yueyue Ding, Haitao Lv

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Proteomics of serum exosomes in children in the acute stage of Kawasaki disease: a prospective study].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yunjia TangThe Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
Wenhua YanThe Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
Ling SunThe Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
Qiuqin XuThe Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
Yueyue DingThe Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China.
Haitao LvThe Department of Cardiology, Children's Hospital of Soochow University, No. 92, Zhongnan Street, Suzhou, 215025, China. haitaoszz@163.com.
Soochow University · CN

Funding

National Natural Science Foundation of China 81570455National Natural Science Foundation of China 81600222National Natural Science Foundation of China 81600391National Natural Science Foundation of China 81700439Natural Science Foundation of Jiangsu Province BE2017660Natural Science Foundation of Jiangsu Province (CN) BK20150291Science and Technology Projects for the Youth of Suzhou KJXW2016021the Foundation of Suzhou government SYS201443
6 · The paper itself

Abstract

Kawasaki disease (KD) is the leading cause of acquired heart disease due to its complicated coronary artery lesions. Up to now, few studies were focused on the status of persistent coronary artery aneurysms (CAA) in KD patients. The present study was designed to identify the coronary artery outcomes and seek the risk factors associated with the regression of CAA in KD patients. One hundred and twenty KD patients with CAA hospitalized in Children's Hospital of Soochow University from Jan 2008 to Dec 2013 were prospectively studied by a 3-year follow-up. Data regarding demographic, clinical, laboratory, and echocardiographic characteristics were documented and further analyzed. It was estimated that 39.2% of the patients had complete regression of CAA within 4 weeks, 59.2% within 8 weeks, and 70.0% within 16 weeks. No fatal cardiac events occurred. We found patients who aged ≤ 1 year, received initial intravenous immunoglobulin (IVIG) treatment after the 10th day of illness, and IVIG non-responders were associated with the regression of persistent CAA. The relative risks were 1.55, 1.87, and 1.88, respectively. Age, initial IVIG treatment, and IVIG response were risk factors of persistent CAA, and more attention should be paid on these patients.

Indexed as

AdolescentAnticoagulantsAntipyreticsAspirinChildChild, PreschoolChinaCoronary AneurysmFemaleFeverFollow-Up StudiesHumansImmunoglobulins, IntravenousInfantMaleMucocutaneous Lymph Node SyndromeAnticoagulantsAntipyreticsAspirinImmunoglobulins, IntravenousWarfarinChildrenCoronary artery aneurysm regressionKawasaki diseaseRisk factors

Identifiers

PMID29330741
OpenAlexW2784163329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.